Skip to main content
logo
Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · Real-Time Price · USD
7.29
-0.04 (-0.55%)
Jul 24, 2026, 4:00 PM EDT - Market closed

Precision BioSciences Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
45.0734.2668.748.7325.1115.53
Revenue Growth
-11.87%-50.12%40.98%94.15%-78.28%375.72%
Gross Profit
45.0734.2668.748.7325.1115.53
Operating Income
129.26120.64163.55141.19112.5270.43
Net Income
-18.44-45.727.17142.4-111.64-30.6
Earnings Per Share
-3.67-3.561.04-15.96-38.10-15.60
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
101.18115.5986.31116.68189.58143.66
Total Debt
28.4728.8130.0531.2724.969.11
Net Cash (Debt)
72.7286.7856.2785.41164.62134.55
Net Cash Growth
53.17%54.22%-34.12%-48.12%22.35%69.72%
Net Cash Per Share
4.366.778.1722.2356.1968.78

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-58.73-65.84-58.45-84.11-45.75-10.85
Capital Expenditures
-0.04-0.09-0.25-1.96-3.32-5.05
Free Cash Flow
-58.77-65.93-58.7-86.07-49.07-15.91
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
286.77%352.09%238.08%289.76%448.26%234.08%
Pretax Margin
274.85%368.26%286.60%292.24%406.02%241.68%
Profit Margin
274.85%368.25%286.60%292.24%406.02%241.68%
FCF Margin
-130.38%-192.41%-85.44%-176.64%-195.52%-13.77%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
--3.66---
PS Ratio
4.172.920.450.945.263.90